• Bayer AG (BAY.F), Onyx Pharmaceuticals, Inc. (ONXX)'s CA Drug Fails Late-stage Trial More...
• Pfizer Inc. (PFE)'s Lyrica Meets Goals in US, Europe Studies More...
• Merck & Co., Inc. (MRK) Reports Positive Isentress Data More...
• Kowa Pharmaceuticals America, Eli Lilly and Company (LLY) Release Results From a Pharmacokinetic Study More...
• OncoSec Medical Inc. OMS ElectroChemotherapy for Head and Neck Cancer Shows Enhanced Quality of Life in Two Randomized Phase III Studies More...
• Orexo AB Reports Positive Feedback from Pre-NDA Meeting With FDA - Clearing Path for Regulatory Submission of OX219 More...
• Vitamin D May Protect Lung Function in Smokers, Brigham and Women's Hospital Study More...
• Mom's HIV Drugs May Pass to Baby in Womb, Breast-Feeding, University of California, San Francisco (UCSF) Study More...
• Snacking and BMI Linked to Double Effect of Brain Activity and Self-Control,University of Exeter Study More...
• Children With Trisomy 13 and 18 and Their Families Appear Happy, Sainte-Justine University Hospital Center and University Of Montreal Study More...
• Type 2 Diabetes Drug, DPP-4 Inhibitor Linagliptin, is Clinically Effective for Long-Term Use, Cardiff University''s Thirty-Two Country Trial Suggests More...
• Galectin Therapeutics Receives U.S. Patent for Potential Ground-Breaking Treatment for Chronic Liver Disease With Fibrosis (Scarring) and Cirrhosis More...
• IntelliCell BioSciences (SVFC) Files Patent Application for a New Research Technique More...
• Derma Sciences, Inc. (DSCI) Announces Issuance of Two New U.S. Patents for DSC127 More...
• Amarin Corporation PLC (AMRN)'s Website Blunder Pushes Shares Higher More...
• Would Higher Severance be the Solution for Merck KGaA (MKGAF.PK) Workers? More...
• Imperial Innovations Pumps $26.5 Million into Cell Medica More...
• PTC Therapeutics, Inc. Closes $30 Million Financing More...
• Chiasma Inc. Closes $38.5 Million Equity Financing More...
• Alexza Pharmaceuticals, Inc. (ALXA) Secures a $20 Million Committed Equity Financing Facility With Azimuth Opportunity, L.P. More...
• Fresenius Kabi AG Buys Fenwal for $1.1 Billion More...
• Boehringer Ingelheim Corporation Buys Funxional Therapeutics Ltd.'s Phase II Respiratory Drug Program More...
• Synergy Pharmaceuticals Signs Definitive Agreement to Acquire Callisto Pharmaceuticals More...
• Sandoz Completes Acquisition of Fougera (AAA), Positioning Sandoz as #1 in Generic Dermatology Globally More...
• Medline Industries, Inc. Acquires Parts of Personal Hygiene Business From Perrigo Company (PRGO) More...
• Basilea Pharmaceutica (BSLN.SW) Announces Completion of Toctino(R) (alitretinoin) Transaction With Stiefel Laboratories More...
• Pacific Biosciences and Imec Announce Collaboration to Develop Advanced Microchips for Single Molecule Sequencing Applications More...
• Wuhan Institute of Biological Products and Refine Technology Collaborate on Vaccines More...
• IFPMA, Biotechnology Industry Organization (BIO) and WADA Advance Anti-Doping Collaboration With the Launch of 2 FIELDS 1 GOAL Campaign More...
• Caisson Biotech, LLC Appoints Biotechnology VeteranGlenn Nedwin CEO and President More...
• BREG, Inc. Appoints Former Integra LifeSciences Corporation (IART) CEO as Chairman of the Board More...
• Pacific Biosciences Names David Botstein, Ph.D. to Its Board of Directors More...
• InterMune, Inc. (ITMN) Reports Second Quarter 2012 Financial Results and Business Highlights More...
• Isis Pharmaceuticals, Inc. (ISIS)' Second Quarter 2012 Financial Results Conference Call More...
• Mentor Capital Cancer Immunotherapy Index Gains 29% During First Half of 2012 More...
• Pfizer Inc. (PFE) Loses Prempro Ruling, Must Pay $10.4 Million More...
• Illumina, Inc. (ILMN) Countersues Intelligent Bio-Systems and QIAGEN N.V. (QGEN) for Patent Infringement More...
• Pfizer Inc. (PFE)'s Lyrica Meets Goals in US, Europe Studies More...
• Merck & Co., Inc. (MRK) Reports Positive Isentress Data More...
• Kowa Pharmaceuticals America, Eli Lilly and Company (LLY) Release Results From a Pharmacokinetic Study More...
• OncoSec Medical Inc. OMS ElectroChemotherapy for Head and Neck Cancer Shows Enhanced Quality of Life in Two Randomized Phase III Studies More...
• Orexo AB Reports Positive Feedback from Pre-NDA Meeting With FDA - Clearing Path for Regulatory Submission of OX219 More...
• Vitamin D May Protect Lung Function in Smokers, Brigham and Women's Hospital Study More...
• Mom's HIV Drugs May Pass to Baby in Womb, Breast-Feeding, University of California, San Francisco (UCSF) Study More...
• Snacking and BMI Linked to Double Effect of Brain Activity and Self-Control,University of Exeter Study More...
• Children With Trisomy 13 and 18 and Their Families Appear Happy, Sainte-Justine University Hospital Center and University Of Montreal Study More...
• Type 2 Diabetes Drug, DPP-4 Inhibitor Linagliptin, is Clinically Effective for Long-Term Use, Cardiff University''s Thirty-Two Country Trial Suggests More...
• Galectin Therapeutics Receives U.S. Patent for Potential Ground-Breaking Treatment for Chronic Liver Disease With Fibrosis (Scarring) and Cirrhosis More...
• IntelliCell BioSciences (SVFC) Files Patent Application for a New Research Technique More...
• Derma Sciences, Inc. (DSCI) Announces Issuance of Two New U.S. Patents for DSC127 More...
• Amarin Corporation PLC (AMRN)'s Website Blunder Pushes Shares Higher More...
• Would Higher Severance be the Solution for Merck KGaA (MKGAF.PK) Workers? More...
• Imperial Innovations Pumps $26.5 Million into Cell Medica More...
• PTC Therapeutics, Inc. Closes $30 Million Financing More...
• Chiasma Inc. Closes $38.5 Million Equity Financing More...
• Alexza Pharmaceuticals, Inc. (ALXA) Secures a $20 Million Committed Equity Financing Facility With Azimuth Opportunity, L.P. More...
• Fresenius Kabi AG Buys Fenwal for $1.1 Billion More...
• Boehringer Ingelheim Corporation Buys Funxional Therapeutics Ltd.'s Phase II Respiratory Drug Program More...
• Synergy Pharmaceuticals Signs Definitive Agreement to Acquire Callisto Pharmaceuticals More...
• Sandoz Completes Acquisition of Fougera (AAA), Positioning Sandoz as #1 in Generic Dermatology Globally More...
• Medline Industries, Inc. Acquires Parts of Personal Hygiene Business From Perrigo Company (PRGO) More...
• Basilea Pharmaceutica (BSLN.SW) Announces Completion of Toctino(R) (alitretinoin) Transaction With Stiefel Laboratories More...
• Pacific Biosciences and Imec Announce Collaboration to Develop Advanced Microchips for Single Molecule Sequencing Applications More...
• Wuhan Institute of Biological Products and Refine Technology Collaborate on Vaccines More...
• IFPMA, Biotechnology Industry Organization (BIO) and WADA Advance Anti-Doping Collaboration With the Launch of 2 FIELDS 1 GOAL Campaign More...
• Caisson Biotech, LLC Appoints Biotechnology VeteranGlenn Nedwin CEO and President More...
• BREG, Inc. Appoints Former Integra LifeSciences Corporation (IART) CEO as Chairman of the Board More...
• Pacific Biosciences Names David Botstein, Ph.D. to Its Board of Directors More...
• InterMune, Inc. (ITMN) Reports Second Quarter 2012 Financial Results and Business Highlights More...
• Isis Pharmaceuticals, Inc. (ISIS)' Second Quarter 2012 Financial Results Conference Call More...
• Mentor Capital Cancer Immunotherapy Index Gains 29% During First Half of 2012 More...
• Pfizer Inc. (PFE) Loses Prempro Ruling, Must Pay $10.4 Million More...
• Illumina, Inc. (ILMN) Countersues Intelligent Bio-Systems and QIAGEN N.V. (QGEN) for Patent Infringement More...
0 comments